uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 07, 2024 07:05 ET
|
uniQure Inc.
uniQure announces first quarter 2024 results
Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
May 07, 2024 07:05 ET
|
Apellis Pharmaceuticals, Inc.
Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® (pegcetacoplan injection) $25.6 million for EMPAVELI® (pegcetacoplan) ...
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
May 07, 2024 07:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
The Joint Corp. to Participate in Upcoming Investor Conferences
May 07, 2024 07:05 ET
|
The Joint Corp.
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation’s largest provider of chiropractic care through The Joint Chiropractic® network, announced that...
Global Regenerative Medicine Industry Analysis Reveals Significant Collaboration and Licensing Trends from 2016 to 2024
May 07, 2024 07:04 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. A comprehensive...
SES’s O3b mPOWER System Launches Service via Gilat’s SkyEdge IV Platform
May 07, 2024 07:03 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
INE Wins Four Cybersecurity Awards in 12th Annual Global InfoSec Awards at #RSAC 2024
May 07, 2024 07:02 ET
|
INE
San Francisco, CA, May 07, 2024 (GLOBE NEWSWIRE) -- INE, a leading provider of cybersecurity certifications and training, is proud to announce it has won four Global InfoSec Awards during RSAC...
Bioinformatic Collaboration and Licensing Deals Analysis Report and Directory 2024
May 07, 2024 07:01 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Bioinformatic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Bioinformatic Collaboration and...
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 07, 2024 07:01 ET
|
Prelude Therapeutics, Inc.
First-in-class IV SMARCA2 degrader, PRT3789 and potentially best-in-class CDK9 inhibitor, PRT2527 remain on track to generate initial proof-of-concept data in 2024 New preclinical data presented at...
First Watch Restaurant Group, Inc. Reports Strong Q1 2024 Financial Results
May 07, 2024 07:00 ET
|
First Watch Restaurant Group, Inc.
Total revenues increased 14.7%; same-restaurant sales growth of 0.5%*Income from operations margin of 5.1% and restaurant level operating profit margin of 20.8%Net income of $7.2 million and Adjusted...